Effects of high dose transdermal nicotine replacement in cigarette smokers
- 31 January 2007
- journal article
- Published by Elsevier BV in Pharmacology Biochemistry and Behavior
- Vol. 86 (1), 132-139
- https://doi.org/10.1016/j.pbb.2006.12.017
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Relationships between Cigarette Consumption and Biomarkers of Tobacco Toxin ExposureCancer Epidemiology, Biomarkers & Prevention, 2005
- The feasibility of smoking reduction: an updateAddiction, 2005
- Both Smoking Reduction With Nicotine Replacement Therapy and Motivational Advice Increase Future Cessation Among Smokers Unmotivated to Quit.Journal of Consulting and Clinical Psychology, 2004
- Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A reviewNicotine & Tobacco Research, 2002
- Reducing tobacco harm: Research challenges and issuesNicotine & Tobacco Research, 2002
- Biochemical verification of tobacco use and cessationNicotine & Tobacco Research, 2002
- Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?Tobacco Control, 1997
- Role of nicotine dose and sensory cues in the regulation of smoke intakePharmacology Biochemistry and Behavior, 1993
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- Signs and Symptoms of Tobacco WithdrawalArchives of General Psychiatry, 1986